Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC
Sponsor: Pharmicell Co., Ltd.
Summary
The goal of this observational study is to learn about the long-term safety of Cellgram-LC in patients with alcoholic liver cirrhosis who previously received Cellgram-LC in the PMC-P-07 study. The main question it aims to answer is: \- Do adverse event of special interest (AESI) or liver transplantation occur during the 5 years after Cellgram-LC administration? Participants who previously received Cellgram-LC in the PMC-P-07 study and voluntarily consent to participate in this long-term follow-up study will be followed for 5 years after Cellgram-LC administration through telephone visits to collect information on AESI and liver transplantation.
Official title: Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
Key Details
Gender
All
Age Range
19 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2021-09-09
Completion Date
2031-12-31
Last Updated
2026-09-21
Healthy Volunteers
No
Conditions
Locations (14)
Korea University Ansan Hospital
Ansan, South Korea
Soonchunhyang University Hospital
Bucheon-si, South Korea
Soonchunhyang University Hospital
Cheonan, South Korea
Gangwon National University Hospital
Chuncheon, South Korea
Hallym Univ. Medical Center
Chuncheon, South Korea
Gangneung Asan Hospital
Gangneung-si, South Korea
Eunpyeong St. Mary's Hospital
Seoul, South Korea
Gangnam Severance Hospital
Seoul, South Korea
Korea University Anam Hospital
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Seoul St. Mary's Hospital
Seoul, South Korea
Soonchunhyang University Hospital
Seoul, South Korea
Wonju Severance Christian Hospital
Wŏnju, South Korea
Yongin Severance Hospital
Yongin, South Korea